Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
Solid Biosciences Inks Deal With Mayo Clinic to Develop Cardiac Gene Therapies
The Mayo Clinic will be responsible for R&D through IND-enabling studies, and Solid will have the option to pursue continued development.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
In Brief This Week: Hemogenyx, Intellia, Care Access
News items for the week of Nov. 25, 2024.
Medera, CADENCE Launch Heart Failure Gene Therapy Trial in Singapore
In the trial, researchers will test how well Medera's SRD-001 gene therapy improves symptoms in heart failure patients with reduced ejection fraction.
AstraZeneca Selects Diabetes Treg Cell Therapy Triggering $10M Payout for Quell Therapeutics
AstraZeneca will take the chosen type 1 diabetes product into preclinical and clinical studies and Quell will provide manufacturing support.